Purchase Order 75D30124P18374
Award Date
12/14/23
Potential Completion Date
3/11/24
Potential Value
$1.9K
Federal Agency
CDC Pittsburgh
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Illumina, Inc. is for the purchase of a NEXTSEQ 1000 SEQ SYSTEM, a genetic sequencing instrument, by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, PA. The $159,600.00 firm fixed-price purchase order does not have a set-aside designation. Illumina is a manufacturer and provider of genetic and genomic analysis instruments and reagents, and has received previous prime contract awards from federal agencies like the NIH, USDA, and VA to support...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents, for the procurement of a NEXTSEQ 1000 SEQUENCING SYSTEM. The total potential value of the award is $205,800.00 with a completion date of August 23, 2021. Illumina has a history of providing sequencing equipment, consumables, and services to federal agencies such as the National...
Illumina, Inc. has been awarded a $97,020 firm fixed price purchase order by the Centers for Disease Control and Prevention (CDC) for an Illumina MiSeq sequencing system. The place of performance is in San Diego, California. No set-aside provision was applied to this acquisition. The CDC is a component of the Department of Health and Human Services that conducts research and provides guidance related to public health issues such as infectious diseases. This purchase will support the CDC's...
This is a $273,825 firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for an AOA 6293 NextSeq 500 gene sequencing system. The contract has no set-aside designation. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. They have provided sequencing systems and related products to support research and diagnostics across various federal agencies, including the NIH, USDA, and VA....
This is a $94,050.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and analysis instruments and reagents. The award is for an Illumina MiSeq sequencing system and does not have a set-aside designation. Illumina has a history of providing sequencing equipment and services to support research and diagnostics across various federal agencies, including the National Institutes of Health, Department of...
This is a firm fixed price purchase order contract awarded to Illumina, Inc., a manufacturer of genomic sequencing and analysis products, by the Centers for Disease Control and Prevention (CDC). The $90,260.40 contract does not have a set-aside designation. Illumina has previously provided sequencing instruments, reagents, and related services to support genomic research and diagnostics across various federal agencies. This award appears to be for the provision of Illumina's sequencing...
The Centers for Disease Control and Prevention (CDC) awarded a $95,931 firm-fixed-price purchase order to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, to provide a MiSeq next-generation DNA sequencing system. This sole-source award is intended to support the CDC's public health need for enhanced monitoring of HIV drug resistance in countries receiving PEPFAR (President's Emergency Plan for AIDS Relief) funding. Illumina was selected as the sole source due to its...
This is a firm fixed price Blanket Purchase Agreement (BPA) call order awarded to Illumina, Inc., a manufacturer of sequencing instruments and reagents, by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The $67,395.38 award is for an "ILLUMINA PRODUCT CARE PLAN" to provide support and maintenance services for Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing platforms used by the CDC. This award is not associated with a set-aside program. Illumina has a...
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $19,502 purchase order to Illumina, Inc. for ISEQ 100NGS kits. The firm fixed price contract has a period of performance of one day, September 6, 2023. The place of performance will be Illumina's location in Atlanta, Georgia. The CDC is likely procuring the next generation sequencing kits to support genomic surveillance efforts within its broader infectious disease programs. No...
This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions, for maintenance, repair, and support services on two Illumina NextSeq 1000 instruments. The $239,670.64 contract has a base period of 12 months and three 12-month option periods, with services to be performed in Atlanta, Georgia. The award was made under simplified acquisition procedures, and there were no set-aside...